ArticleNature2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
Open access · hybridAbstract read
In one paragraph
Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.
0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
38.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
117 citing papers in PubMed, 200 citations in OpenAlex.
- Distribution of HLA-DRB1 Alleles and Genotypes With Respect to Plasma Anti-SARS-CoV-2 IgG Titres Among COVID-19-Vaccinated Bangladeshi Adults.Annals of human genetics · 2026Article
- HLA-II peptide-binding diversity shapes humoral immune responses and susceptibility to infections.Nature communications · 2026Article
- Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV.Human immunology · 2026Article
- COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.Research square · 2026Article
- Distinct CD8iScience · 2026Article
- Comprehensive longitudinal profiling identifies differential frequency, epitope specificity, and effector function of CD8EBioMedicine · 2026Article
- Discordant Outcomes of SARS-CoV-2 Exposure in Household Contacts.Clinical immunology communications · 2026Article
- HLA Class I and II Variants as Potential Determinants of Clinical Severity and Mortality in Patients with COVID-19: A Prospective Study from Saudi Arabia.Biomedicines · 2026Article
- Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape.JCI insight · 2026Article
- Widespread SARS-CoV-2 Transmission Despite Limited Reported Cases and Clinical Disease: Exploring the Role of Pre-Existing Humoral Immunity to SARS-CoV-2 in Eastern Sierra Leone.Immunity, inflammation and disease · 2026Article
- Evolution of Resistance to Avian Malaria Infection in an Endemic Hawaiian Honeycreeper.Ecology and evolution · 2026Article
- Immunological memory to vaccines.Immunity · 2026Review
- Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity.Journal of translational medicine · 2026Article
- Article
- A Lung-Immune Dual-Humanized Mouse Using Cryopreserved Tissue Enables Infection and Immune Profiling of Human Common Cold Coronaviruses.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors.Research square · 2026Article
- Inference of SARS-CoV-2 exposure biomarkers using large-scale T-cell repertoire profiling.Genome medicine · 2026Article
- Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.Cancer discovery · 2026Article
- Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors.bioRxiv : the preprint server for biology · 2026Article
- CEI: A Clonal Expansion Identifier for T-cell receptor clones following SARS-CoV-2 vaccination.ArXiv · 2026Article
57 more citing papers are in PubMed but not listed here.
Corrections and comments
- Update of
Authors and funding
39 authors at 6 institutions in 3 countries.
Danillo G Augusto *Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0001-5665-8547
Lawton D Murdolo *Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.ORCID 0000-0001-5222-9585
Demetra S M Chatzileontiadou *Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.ORCID 0000-0003-1132-8952
Joseph J SabatinoWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Tasneem YusufaliWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Noah D PeyserDivision of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-4529-8325
Xochitl ButcherDivision of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
Kerry KizerWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Karoline GuthrieWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Victoria W MurrayDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0002-4479-2359
Vivian PaeDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Sannidhi SarvadhavabhatlaDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Fiona BeltranDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Gurjot S GillDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Kara L LynchDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.
Cassandra YunDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0002-6971-2060
Colin T MaguireClinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-7890-8375
Michael J PelusoDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-0585-6230
Rebecca HohDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Timothy J HenrichDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Steven G DeeksDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-6371-747X
Michelle DavidsonDepartment of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0002-5518-9774
Scott LuDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Sarah A GoldbergDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.ORCID 0000-0002-8642-1468
J Daniel KellyDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.ORCID 0000-0002-7616-0321
Jeffrey N MartinDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Cynthia A Vierra-GreenCIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Stephen R SpellmanCIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
David J LangtonExplantLab, Newcastle-upon-Tyne, UK.ORCID 0000-0003-1178-3031
Michael J Dewar-OldisDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.
Corey SmithQIMR Berghofer Centre for Immunotherapy and Vaccine Development Brisbane, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Peter J BarnardDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.ORCID 0000-0003-1755-7991
Sulggi LeeDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-1560-2250
Gregory M MarcusDivision of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-5197-7696
Jeffrey E OlginDivision of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
Mark J PletcherDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Martin MaiersCIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Stephanie GrasDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.ORCID 0000-0001-7416-038X
Jill A HollenbachWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. jill.hollenbach@ucsf.edu.ORCID 0000-0001-6572-7962
University of California, San Francisco · USLa Trobe University · AUNational Marrow Donor Program · USQIMR Berghofer Medical Research Institute · AUUniversity of North Carolina at Charlotte · USUniversity of Utah · US
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MCTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9MInsights Into Immune-Related Diseases Born from Population GenomicsU01AI090905 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2010 to 2026
$10.9MThe Health ePeople Resource for Mobilized ResearchU2CEB021881 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARCUS, GREGORY M, OLGIN, JEFFREY E · 2015 to 2020
$10.3MTraining in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4MMHC Variation in Host Response to SARS-CoV2 and COVID-19 OutcomesR01AI159260 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOLLENBACH, JILL ALLISON · 2021 to 2025
$4.0MCharacterizing the virologic and immunologic signatures of HIV exceptional controlK23AI157875 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PELUSO, MICHAEL JOSEPH · 2021 to 2025
$927kUnderstanding the epidemiology and natural history of unrecognized Ebola virus infectionK23AI146268 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KELLY, JOHN DANIEL · 2019 to 2022
$748kDiversity Supplement: Defining Variation in the Natural Killer Cell Receptome in Human PopulationsR21HG012386 · NHGRI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI AUGUSTO, DANILLO G · 2022 to 2024
$729kNCATS NIH HHS UM1 TR004409NCI NIH HHS U24 CA076518NHGRI NIH HHS R21 HG012386NIAID NIH HHS K23 AI146268NIAID NIH HHS K23 AI157875NIAID NIH HHS L30 AI126521NIAID NIH HHS L30 AI147159NIAID NIH HHS R01 AI159260NIAID NIH HHS T32 AI060530NIAID NIH HHS U01 AI090905NIBIB NIH HHS U2C EB021881
Abstract
Studies have demonstrated that at least 20% of individuals infected with SARS-CoV-2 remain asymptomatic
Indexed as
AllelesAsymptomatic InfectionsCOVID-19HLA-B AntigensCohort StudiesCross ReactionsEpitopes, T-LymphocyteHumansImmunodominant EpitopesPeptidesSARS-CoV-2Spike Glycoprotein, CoronavirusT-LymphocytesEpitopes, T-LymphocyteHLA-B AntigensImmunodominant EpitopesPeptidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.